Tag: cardiovascular
New ESC guidelines combine peripheral arterial and aortic diseases for first...
The European Society of Cardiology (ESC) has today published its 2024 guidelines for the management of peripheral arterial and aortic diseases (PAAD), evaluating these...
IsomAb announces close of £7.5 million financing to accelerate lead candidate...
IsomAb Ltd, a UK-based biotechnology company, has announced the closing of a £7.5 million (approximately US$9.4 million) seed financing round, led by Broadview Ventures, with...
Shape Memory Medical announces sublicense of intellectual property
Shape Memory Medical has announced that it has entered into a sublicense agreement with "a global medtech market leader" in a press release. Under...
Death due to cardiovascular disease more likely among Black adults born...
Black adults born in the USA had a higher rate of death from cardiovascular diseases and all causes compared to Black adults who were born...
Jeremy Durack and John Simpson to join Cordis-X innovation accelerator
Ajax Health has announced the appointments of two cardiovascular professionals to Cordis-X, an independent accelerator created to drive innovation and growth to Cordis.
"Since the...
Research reveals improved outcomes and decreased mortality in management of aortic...
The Minneapolis Heart Institute Foundation (MHIF; Minneapolis, USA) has announced the publication of research showing improved patient outcomes and significantly decreased 30-day mortality in...
Vascular disease in COVID-19 is not caused by viral infection of...
The SARS-CoV-2 virus does not infect blood vessels, despite the high risk of blood clots to COVID-19 patients, University of Queensland (UQ) researchers have...
AHA scientific statement provides update on epidemiology, diagnosis, and management of...
The American Heart Association (AHA) has released a new scientific statement on lower extremity peripheral arterial disease (PAD), focusing on contemporary epidemiology, management gaps,...
Brilinta reduces risk of cardiovascular events in patients with coronary artery...
AstraZeneca has announced detailed results from the positive Phase III THEMIS trial, which showed BRILINTA (ticagrelor) plus aspirin reduced the relative risk for...
Be an early adopter of AI to harness its benefits
Artificial intelligence (AI) is already better than humans at reading specific radiographic findings. It will impact phycisians’ jobs, but because it can currently only...
